In immune cell enriched regions, STAG3, APCS, USP51, C7, CACNB1, and GLS2 were associated with the survival of NPC patients (P < 0.05) (Figures 6C, S2D). The gene discussed is GLS2; the disease is nasopharyngeal carcinoma.